Form 8-K Lyra Therapeutics, Inc. For: Feb 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
NASDAQ moves to delist Lyra Therapeutics over public shell concerns
February 6, 2026 4:14 PM ESTLyra Therapeutics Inc. (NASDAQ: LYRA) received a delisting determination from NASDAQ on February 2, 2026, according to a company statement based on a staff letter from the exchange's Listing Qualifications Department.
NASDAQ cited the company as a "public shell" under Listing Rule 5101, referencing Lyra's January 12, 2026 Form 8-K filing that... More
